FrançaisAre analysts right about Synopsys (SNPS)?
📈 See the interactive version (live chart) →
Historical analyst accuracy
For Synopsys, we replayed every analyst price target of the past 12 months and measured the real outcome: 47% were profitable, average return +19% (212 calls). At 3 months: +3% average return (40% profitable). The higher the %, the more often analysts were right on this stock.
Most reliable analysts on this stock (past track record)
Their past track record on this stock (targets replayed against real prices) — not a forecast of what will happen.
| Analyst / broker | Calls i | % profitable i | Avg return i |
|---|---|---|---|
| Keybanc | 31 | 55% | +25% |
| Rosenblatt | 27 | 33% | +13% |
| Needham | 24 | 38% | +12% |
| Baird | 21 | 62% | +25% |
| Wells Fargo | 20 | 60% | +29% |
Valuation
Is Synopsys overvalued, and is it a good time to buy Synopsys right now? If you're wondering, here's a recap to make up your own mind: Synopsys's valuation vs its sector median, to weigh alongside analyst reliability (above) and past performance. Educational information, not buy advice.
The P/E (price ÷ earnings per share) = how many years of earnings you pay for the stock. The higher it is, the more growth the market expects — but the pricier the stock, so more vulnerable if growth disappoints. The forward P/E uses next year's expected earnings: lower than the current P/E = rising expected earnings. We compare it to the sector median to see whether the stock is expensive relative to its peers.
| Metric | Synopsys | Sector median (Information Technology) |
|---|---|---|
| P/E | 71.4 | 39.4 |
| Forward P/E | 26.6 | 20.6 |
| Net margin | 9% | 16% |
👉 Synopsys trades above its sector median (71.4 vs 39.4) — the market expects higher growth; watch out for disappointment.
📖 P/E, PEG, margin…: see the glossary
Frequently asked questions
Is Synopsys a buy right now?
The analyst consensus on Synopsys (SNPS) is "Buy" (31 bullish, 3 bearish calls over 12 months). This is not advice: historically, 47% of their targets on this stock turned out profitable over 1 year.
What is Synopsys's price target?
The median 12-month price target is $572 (+23% vs $465), ranging from $450 to $610 (10 analysts).
Are analysts accurate on Synopsys?
Over 1 year, 47% of analyst targets on Synopsys were profitable, for an average return of +19% (across 212 timestamped calls). This is JPI Invest's accuracy metric.
What is the Synopsys stock forecast?
Analysts target a median of $572 within 12 months, i.e. +23% vs the current price. The most bullish targets $610, the most cautious $450.
What is the Synopsys stock forecast for 2026 or long term (2030)?
Note: analyst targets are 12-month (median $572, +23%), NOT 2030. No reliable 5-10 year price forecast exists (« 2030 prediction » models are speculative). The most useful inputs: the 12-month median above, these analysts' historical accuracy (47%), and the stock's past trajectory.
Is Synopsys overvalued?
Its P/E is 71.4, forward P/E 26.6. A forward P/E lower than the current P/E means earnings are expected to grow.
📊 See the full interactive analysis of Synopsys →
What is JPI Invest?
JPI Invest aggregates analyst recommendations across the entire S&P 500 (plus the S&P MidCap 400), replays them against real prices and measures who predicts best — on results, not reputation. Instead of taking a price target at face value, you see each analyst's track record on each stock.
- 🏆 Analyst leaderboard by real reliability (beating their sector, not just riding the rally)
- 🎯 What to buy: 3 backtested methods over 6 years, from cautious to aggressive
- 💬 AI assistant: ask anything about any stock, with the numbers
- 📊 Portfolio tracking + 🔔 price alerts by email
⚠️ Educational information, not investment advice. Analyst price targets are 12-month and can be wrong. Data via Yahoo Finance, recomputed by JPI Invest.